-
1
-
2
-
3
Appendicitis After Initiation of Tirzepatide
Published 2025-01-01“…Garrett Chan1, Mariam Ansar1, Marlena Klein1,21Department of Internal Medicine, Cooper University Hospital, Camden, New Jersey, USA; 2Cooper Medical School of Rowan University, Camden, New Jersey, USACorrespondence: Garrett Chan, Email chan-garrett@cooperhealth.eduAbstract: Tirzepatide is a GLP1/GIP receptor agonist that is used to treat type 2 diabetes and promote weight loss. …”
Get full text
Article -
4
-
5
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis
Published 2020-09-01Get full text
Article -
6
-
7
-
8
-
9